recurrent gallbladder cancer
Showing 1 - 25 of >10,000
Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type, Metastatic Pancreatic
Active, not recruiting
- Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
- +27 more
- Durvalumab
- Guadecitabine
-
Los Angeles, California
- +2 more
Aug 5, 2022
Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer Trial (CTX-009, Paclitaxel)
Not yet recruiting
- Biliary Tract Cancer
- +3 more
- (no location specified)
Aug 16, 2022
Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- +15 more
- Cisplatin
- +6 more
-
Los Angeles, California
- +1 more
Aug 5, 2022
Metastatic Distal Bile Duct Adenocarcinoma, Metastatic Gallbladder Carcinoma, Metastatic Intrahepatic Cholangiocarcinoma Trial
Recruiting
- Metastatic Distal Bile Duct Adenocarcinoma
- +9 more
- Atezolizumab
- +6 more
-
Phoenix, Arizona
- +28 more
Dec 31, 2022
Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial
Not yet recruiting
- Recurrent Biliary Tract Carcinoma
- +13 more
- Binimetinib
- +10 more
- (no location specified)
Nov 8, 2022
Unresectable Gallbladder Cancer Trial in Guangzhou (Carrilizumab plus GEMOX)
Not yet recruiting
- Unresectable Gallbladder Cancer
- Carrilizumab plus GEMOX
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Jun 16, 2023
Robot-assisted vs Laparoscopic vs Open Radical Cholecystectomy
Enrolling by invitation
- Gallbladder Cancer
- Minimally invasive surgery
-
Barcelona, SpainHospital del Mar
Sep 25, 2023
Gallbladder Cancer Trial in Varanasi (Everolimus 10 mg, Standard of care)
Recruiting
- Gallbladder Cancer
- Everolimus 10 mg
- Standard of care
-
Varanasi, UP, IndiaBanaras Hindu University
Apr 18, 2023
Deep Learning Radiogenomics For Individualized Therapy in
Recruiting
- Gallbladder Cancer
- CT scan
-
Chandigarh, Punjab, IndiaPost Graduate Institute of Medical Education and Research
Feb 6, 2023
Gallbladder Cancer, Initially Unresectable, the First Line Treatment Trial in Shanghai (Combination of Gemcitabine,
Recruiting
- Gallbladder Cancer
- +2 more
- Combination of Gemcitabine, Nab-paclitaxel, Sintilimab and Bevacizumab
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 24, 2023
Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer Trial in Tianjin
Recruiting
- Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Nov 16, 2022
Stage II Gallbladder Cancer AJCC v8, Stage IIA Gallbladder Cancer AJCC v8, Stage IIB Gallbladder Cancer AJCC v8 Trial in Atlanta
Recruiting
- Stage II Gallbladder Cancer AJCC v8
- +5 more
- Cisplatin
- +3 more
-
Atlanta, GeorgiaEmory University, Winship Cancer Institute
Jan 3, 2023
Gallbladder Adenocarcinoma Trial in Morgantown (HIPEC)
Not yet recruiting
- Gallbladder Adenocarcinoma
-
Morgantown, West VirginiaWest Virginia University Cancer Institute Mary Babb Randolph Can
Jun 23, 2022
Gallbladder Cancer Trial in Varanasi (Next generation sequencing)
Recruiting
- Gallbladder Cancer
- Next generation sequencing
-
Varanasi, UP, IndiaBanaras Hindu University
Jun 2, 2022
Poorly Differentiated Adenocarcinoma With Signet Ring Cells of
Completed
- Gallbladder Cancer
- laparoscopic whole-layer cholecystectomy
-
Ōita, Oita, Japanoita Red Cross hospital
Sep 24, 2022
Gallbladder Cancer Unresectable Trial in Lucknow (chemoradiation)
Recruiting
- Gallbladder Cancer Unresectable
- chemoradiation
-
Lucknow, Uttar Pradesh, IndiaSanjay Gandhi Postgraduate Institute of Medical Sciences
Aug 6, 2022
Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,
Active, not recruiting
- Advanced Bile Duct Carcinoma
- +17 more
- Irinotecan
- +2 more
-
Rochester, MinnesotaMayo Clinic
Jan 5, 2023
Cholangiocarcinoma, Stage III Gallbladder Cancer AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7 Trial in Scottsdale, Rochester
Active, not recruiting
- Cholangiocarcinoma
- +6 more
- Laboratory Biomarker Analysis
- Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102
-
Scottsdale, Arizona
- +1 more
Jan 4, 2023
Exploration of Locally Recurrent Colorectal Cancer
Recruiting
- Locally Recurrent Colorectal Cancer
- salvage surgery
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences & Peking Un
Oct 28, 2023
Cadonilimab in Recurrent or Metastatic Cervical Cancer
Not yet recruiting
- Recurrent or Metastatic Cervical Cancer
- (no location specified)
Nov 23, 2023
Incidental Gallbladder Carcinoma, Biliary Tract Cancer Trial in Frankfurt (Gemcitabine, Cisplatin, Oncologically radical
Recruiting
- Incidental Gallbladder Carcinoma
- Biliary Tract Cancer
- Gemcitabine
- +3 more
-
Frankfurt, GermanyKrankenhaus Nordwest gGmbH
Sep 7, 2022
Ovarian Cancer Recurrent Trial (Fluzopril Combined With Apatinib)
Not yet recruiting
- Ovarian Cancer Recurrent
- Fluzopril Combined With Apatinib
- (no location specified)
Oct 22, 2023
Recurrent Prostate Cancer Patients
Not yet recruiting
- Recurrent Prostate Cancer
-
San Francisco, CaliforniaPower Life Sciences
Sep 30, 2023